SELLAS Life Sciences Group, Inc. (SLS)
2.01
+0.05
(+2.55%)
USD |
NASDAQ |
Dec 11, 16:00
2.05
+0.04
(+1.99%)
After-Hours: 06:46
SELLAS Life Sciences Group Free Cash Flow: -30.62M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Geron Corp. | -132.68M |
| GT Biopharma, Inc. | -11.36M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
| Theriva Biologics, Inc. | -18.51M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.068M |
| Cash from Financing (Quarterly) | 26.09M |
| Free Cash Flow Per Share (Quarterly) | -0.0652 |
| Free Cash Flow to Equity (Quarterly) | -6.93M |
| Free Cash Flow to Firm (Quarterly) | -7.068M |
| Free Cash Flow Yield | -16.53% |